Dapagliflozin Effect in Cognitive Impairment in Stroke Trial

NCT05565976 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

270

Enrollment

OTHER

Sponsor class

Conditions

Stroke, Ischemic
Mild Cognitive Impairment
Dementia, Vascular
Metabolic Syndrome

Interventions

DRUG: Dapagliflozin 10mg Tab
DRUG: Statins (Cardiovascular Agents)
DRUG: Platelet Antiaggregant
DRUG: Antidiabetic

Sponsor

Jaime Daniel Mondragon

Collaborators

[object Object]
[object Object]
[object Object]